These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3674659)

  • 21. Palliative aspects of recurrent respiratory papillomatosis.
    Johnson K; Derkay C
    Otolaryngol Clin North Am; 2009 Feb; 42(1):57-70, viii. PubMed ID: 19134490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to the comment by Valentin Gerein on the article, "Lower airway papillomatosis in children".
    Zawadzka-Glos L
    Int J Pediatr Otorhinolaryngol; 2005 Jan; 69(1):131-2. PubMed ID: 15627462
    [No Abstract]   [Full Text] [Related]  

  • 23. Recurrent respiratory papillomatosis.
    Lancet; 1988 Dec; 2(8625):1406. PubMed ID: 2904531
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy in papillomatosis of the respiratory tract].
    Voznesenskaia IA
    Vestn Otorinolaringol; 1969; 31(1):65-9. PubMed ID: 5376676
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment].
    Geraĭn V; Chireshkin DG
    Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent respiratory papillomatosis: update 2008.
    Gallagher TQ; Derkay CS
    Curr Opin Otolaryngol Head Neck Surg; 2008 Dec; 16(6):536-42. PubMed ID: 19005325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further observations on the treatment of recurrent respiratory papillomatosis with interferon: a comparison of sources.
    Sessions RB; Goepfert H; Donovan DT; Dichtel WJ; Gutterman JU
    Ann Otol Rhinol Laryngol; 1983; 92(5 Pt 1):456-61. PubMed ID: 6194728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of laryngotracheal papillomatosis with combined use of laser surgery and intralesional administration of alpha-interferon (Roferon)].
    Walther EK; Herberhold C
    Laryngorhinootologie; 1993 Oct; 72(10):485-91. PubMed ID: 8267824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I toxicity study of human rDNA interferon in patients with solid tumours.
    Wagstaff J; Chadwick G; Howell A; Thatcher N; Scarffe JH; Crowther D
    Cancer Chemother Pharmacol; 1984; 13(2):100-5. PubMed ID: 6467493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
    Vacher S; Peytral C; Narcy P
    Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of patients with respiratory papillomatosis: experience analysis].
    Zegner VG; Ashurov ZM; Sloeva AI
    Vestn Ross Akad Med Nauk; 2005; (5):25-8. PubMed ID: 15960200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent respiratory papillomatosis.
    Kashima HK; Mounts P; Shah K
    Obstet Gynecol Clin North Am; 1996 Sep; 23(3):699-706. PubMed ID: 8869953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interferon in the treatment of recurrent laryngeal papillomas].
    Lenarcić-Cepelja I; Krajina Z
    Laryngol Rhinol Otol (Stuttg); 1984 Aug; 63(8):401-2. PubMed ID: 6482620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Bodenstein H; Pfreundschuh M; Rebmann U; Metzner B; Illiger HJ; Jakse G; Niesel T
    J Clin Oncol; 1995 Feb; 13(2):497-501. PubMed ID: 7844611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.
    Naiman HB; Doyle AT; Ruben RJ; Kadish AS
    Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):483-7. PubMed ID: 6437314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
    Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
    Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha therapy of renal cancer.
    Neidhart JA; Gagen MM; Young D; Tuttle R; Melink TJ; Ziccarrelli A; Kisner D
    Cancer Res; 1984 Sep; 44(9):4140-3. PubMed ID: 6378379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
    Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
    Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study.
    Endres DR; Bauman NM; Burke D; Smith RJ
    Ann Otol Rhinol Laryngol; 1994 Apr; 103(4 Pt 1):301-5. PubMed ID: 8154772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.